retatrutide benefits clinical trials VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide benefits clinical trial retatrutide

Spontaneously reported symptomatic episodes of unconfirmed hypoglycemia were reported by 46 (1.6%) of 2,962 SAXENDA-treated patients and 19 (1.1%) of 1,729 placebo-treated patients

*Vitamin B6 contributes to the regulation of hormonal activity

550 CBT and mindfulness-based stress reduction have been shown to improve coping strategies and reduce pain perception, thereby enhancing overall treatment outcomes

July 23 to 24, 2026 Meeting of the Pharmacy Compounding Advisory Committee

Solid-phase peptide synthesis (SPPS) the workhorse for many GLP-1 APIs generates large volumes of solvent and resin waste

Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to alzheimer disease pathogenesis